Fund Holdings — BVF INC/IL

Total Portfolio Value:
$2.45B
Total Bought:
$309.24M
Total Sold:
$174.95M
Net Transaction:
+$134.28M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
MoonLake ImmunotherapeuticsCL A(MLTX)19,751,28419,751,2840$1.07B$771.68M31.45%-$297.85M
Axsome Therapeutics, Inc.(AXSM)1,388,0641,690,221+302,157$117.44M$197.13M8.03%+$79.69M
Revolution Medicines, Inc.(RVMD)4,181,1794,982,384+801,205$182.88M$176.18M7.18%-$6.71M
Kymera Therapeutics, Inc.(KYMR)5,161,8015,161,8010$207.66M$141.28M5.76%-$66.38M
Mirum Pharmaceuticals, Inc.(MIRM)2,796,5132,796,5130$115.64M$125.98M5.13%+$10.35M
Protagonist Therapeutics Inc1,900,0152,575,015+675,000$73.34M$124.53M5.08%+$51.19M
GH Research PLC(GHRS)10,400,1588,827,712-1,572,446$72.80M$97.37M3.97%+$24.57M
Xoma Royalty Corporation3,633,7432,983,026-650,717$95.49M$59.45M2.42%-$36.04M
Ionis Pharmaceuticals, Inc.(IONS)01,913,385+1,913,385$0$57.73M2.35%+$57.73M
Zymeworks Inc.(ZYME)4,308,9354,308,9350$63.08M$51.32M2.09%-$11.76M
Kura Oncology, Inc.(KURA)2,567,4697,754,129+5,186,660$22.36M$51.18M2.09%+$28.81M
Cullinan Therapeutics, Inc.(CGEM)5,750,6835,750,6830$70.04M$43.53M1.77%-$26.51M
AC Immune SASHS(ACIU)19,522,43619,822,436+300,000$52.71M$37.07M1.51%-$15.64M
Tyra Biosciences, Inc.(TYRA)3,944,1943,944,1940$54.82M$36.68M1.50%-$18.14M
Lakefront Biotherapeutics NVADR(LKFT)1,569,4221,454,422-115,000$43.16M$36.54M1.49%-$6.62M
Celcuity Inc.(CELC)3,466,0003,466,0000$45.37M$35.04M1.43%-$10.33M
Verve Therapeutics Inc6,904,0506,904,0500$38.94M$31.55M1.29%-$7.39M
Structure Therapeutics IncADS1,771,4171,771,4170$48.04M$30.66M1.25%-$17.38M
Xencor, Inc.(XNCR)2,288,7602,740,141+451,381$52.60M$29.16M1.19%-$23.44M
Monte Rosa Therapeutics, Inc.(GLUE)2,764,4715,660,132+2,895,661$19.19M$26.26M1.07%+$7.08M
Septerna, Inc.(SEPN)2,452,0244,396,124+1,944,100$56.15M$25.45M1.04%-$30.70M
Eledon Pharmaceuticals, Inc.(ELDN)6,293,2826,293,2820$25.93M$21.33M0.87%-$4.59M
Cidara Therapeutics Inc1,092,796924,642-168,154$29.37M$19.92M0.81%-$9.46M
Olema Pharmaceuticals, Inc.(OLMA)5,715,8935,295,893-420,000$33.32M$19.91M0.81%-$13.41M
Palvella Therapeutics, Inc.(PVLA)696,555696,5550$8.36M$19.50M0.79%+$11.14M
Foghorn Therapeutics Inc.(FHTX)5,302,0005,302,0000$25.03M$19.35M0.79%-$5.67M
Iteos Therapeutics Inc2,325,0003,075,000+750,000$17.86M$18.36M0.75%+$501.8K
4d Molecular Therapeutics In2,670,6424,561,289+1,890,647$14.88M$14.73M0.60%-$142.5K
Essa Pharma Inc8,748,6298,748,6290$15.66M$13.82M0.56%-$1.84M
Annexon, Inc.(ANNX)7,000,0007,000,0000$35.91M$13.51M0.55%-$22.40M
Verastem, Inc.(VSTM)2,100,4682,100,4680$10.86M$12.67M0.52%+$1.81M
Rapt Therapeutics Inc9,237,5569,237,5560$14.60M$11.27M0.46%-$3.33M
Repare Therapeutics Inc10,333,60010,333,6000$13.54M$10.19M0.42%-$3.35M
Immunic, Inc.(IMUX)8,902,9728,902,9720$8.90M$9.70M0.40%+$801.3K
Avalo Therapeutics, Inc.(AVTX)1,036,6791,036,6790$7.70M$8.30M0.34%+$601.3K
Third Harmonic Bio Inc2,372,9332,372,9330$24.42M$8.23M0.34%-$16.18M
Vigil Neuroscience Inc1,813,6334,013,633+2,200,000$3.08M$7.14M0.29%+$4.06M
TScan Therapeutics, Inc.(TCRX)2,989,4744,889,474+1,900,000$9.09M$6.75M0.28%-$2.34M
Molecular Partners AGADS(MOLN)1,353,9681,353,9680$6.46M$5.51M0.22%-$947.8K
Ikena Oncology Inc4,006,5644,006,5640$6.57M$5.13M0.21%-$1.44M
Forte Biosciences Inc594,282594,2820$13.50M$4.61M0.19%-$8.88M
Allakos Inc16,552,41716,552,4170$20.03M$3.77M0.15%-$16.26M
CytomX Therapeutics, Inc.(CTMX)5,228,4615,228,4610$5.39M$3.32M0.14%-$2.06M
Tenax Therapeutics, Inc.(TENX)339,549339,5490$2.10M$2.22M0.09%+$122.2K
Inventiva S.A.ADS(IVA)686,040686,0400$1.47M$2.06M0.08%+$583.1K
Glycomimetics Inc9,544,2629,544,2620$2.38M$2.00M0.08%-$372.2K
SAB Biotherapeutics, Inc.(SABS)917,826917,8260$3.51M$1.24M0.05%-$2.27M
Newamsterdam Pharma Company
ORDINARY SHARES
059,065+59,065$0$1.21M0.05%+$1.21M
Ovid Therapeutics Inc.(OVID)3,853,8183,853,8180$3.60M$1.20M0.05%-$2.40M
Engene Holdings IncW EXP 10 31 202
*W EXP 10/31/202
945,402945,4020$803.7K$605.1K0.02%-$198.6K
Nls Pharmaceutics Ltd143,676143,6760$303.2K$221.3K0.01%-$81.9K
89bio Inc4,333,8850-4,333,885$33.89M$0—-$33.89M
Agios Pharmaceuticals, Inc.(AGIO)1,073,7550-1,073,755$35.28M$0—-$35.28M
Elevation Oncology Inc2,966,8360-2,966,836$1.67M$0—-$1.67M
Engene Holdings Inc
COM
2,106,0370-2,106,037$14.01M$0—-$14.01M
Page 1 of 1
BVF INC/IL — 13F Holdings — Q1 2025 | TickerTrail